Reviewing the journey to the clinical application of bacteriophages to treat multi-drug-resistant bacteria
Antimicrobial resistance (AMR) was a leading cause of death globally in 2019. Sadly, COVID-19 has exacerbated AMR, nonetheless, the process of developing new antibiotics remains very challenging. This urgently requires the adoption of alternative approaches to treat multi-drug-resistant bacterial infections. This editorial introduces the ‘Bacteriophages against multi-drug resistant bacteria’ collection launched at BMC Infectious Diseases which highlights progress towards using bacteriophages to tackle AMR.
Join the AMR Insights Ambassador Network today!
Connect to over 650 AMR professionals and students in 65 countries!